Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxicrop is a pioneer in the development and manufacture of seaweed-based biostimulants and fertilizers for agriculture, horticulture, and home gardening. Founded on the utilization of Ascophyllum nodosum seaweed harvested from the North Atlantic, the company produces high-quality extracts that enhance plant growth, improve resistance to environmental stress, and boost crop yields. While primarily focused on the agricultural sector, Maxicrop operates within the broader life sciences industry by applying biological and chemical engineering to plant health. The company is a subsidiary of the Valagro Group, which is itself part of Syngenta Biologicals, positioning Maxicrop within a global network of agricultural biotechnology leaders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maxicrop.